FDA Panel Advises Stronger Warnings on Fluoroquinolones
An FDA Advisory Panel reviewed the safety of fluoroquinolones and their use to treat sinus infections, urinary-tract infections and bronchitis.
News
Hip Fracture Risk Factors in the Elderly
As risk of hip fracture increases with advanced age, our knowledge of risk factors for hip fracture among very old people remains limited.
Knee OA (not Hand) is Associated with Higher Mortality in Women
"Doc....the pain is killing me."
This oft heard patient complaint may be truer than you think.
Features Predict Chronicity in Myositis
Certain serologic and clinical features can help predict a chronic disease course among children with juvenile idiopathic inflammatory myopathies (JIIM), a large registry study showed.
Biosimilars and the FDA
Biosimilars are in the news and will be prominently on parade at next week's ACR meeting in San Francisco. Biosimilars are similar to, but not the same as, innovator biologics.
Increasing Trends for Prescription Drugs, But Not for Arthritis Drugs
JAMA reports the results of trends in drug use in the USA over a 13 year period using data derived 37959 adults survey in the National Health and Nutrition Examination Survey (NHANES).
Increasing Risk of Septic Arthritis with Age
A retrospective population-based study from New Zealand examined the epidemiology, clinical features, and microbiology of adult native joint septic arthritis.
Economic Burden of ANCA-Associated Vasculitis in the USA
To assess the prevalence and magnitude of healthcare costs associated with granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) in the USA, researchers analyzed adminstrative data from Truven Health MarketScan Commercial and Medicare Supplemental databases.
Wine, Lupus, Pregnancy and Biosimilars: October 2015 -Top Social Media News
In October 2015, RheumNow published 76 tweets about impactful news, research and teaching points that impact the rheumatology community. In October, RN had a reach (impressions) of 49,500, 79 mentions, and over 2000 visits to RheumNow.com to check out what we publish.
More Adverse Events with Off-Label Drug Use
Off-label use of prescription drugs was associated with adverse drug events in a study of patients in Canada, according to an article published online by JAMA Internal Medicine.
Repeat Skin Cancer Risk with Methotrexate and Biologics
Using Medicare claims data, a retrospective cohort study analyzed the risk of a second non-melanomatous skin cancer (NMSC) in 9460 individuals (6841 with RA and 2788 with IBD).
DSB: Drug Shortages - October 2015
Each month, RheumNow reviews compiled listings of drug shortages germane to the practive of rheumatology using several sources. If you have suggestions or information about specific drug shortages or drug safety issues please email us at info@rheumnow.
